Poly Medicure to use Rs 10 billion fundraise for capex and acquisitions

  • Industry News
  • Sep 18,24
Expansion efforts are underway in areas such as cardiology, critical care, and renal diagnostics, focusing on manufacturing to broaden its market presence.
Poly Medicure to use Rs 10 billion fundraise for capex and acquisitions

Medical devices company Poly Medicure (Polymed) is gearing up for acquisitions in the technology sector and capital expenditure (capex) following a Rs 10 billion fundraising through a qualified institutional placement. Himanshu Baid, Managing Director, stated that Rs 2.5 billion will be allocated for acquisitions, particularly in technology, while another Rs 2.5 billion is set aside for general corporate purposes.

Baid mentioned that they are open to acquiring companies globally, especially those offering technology that can help scale their business. He highlighted the long gestation period of the medtech industry, which typically requires a couple of years to establish a new plant and an additional 18 months for regulatory approvals and clinical trials. To expedite growth, the company sees acquisitions as a quicker route.

Half of the raised funds will be deployed for new capex, which is set to commence now and be completed by the end of 2025-26. Polymed is also focusing on expanding its product portfolio across its six core therapy areas: infusion therapy, vascular access, transfusion systems, cardiology, critical care, and renal diagnostics. The plan is to introduce two to three new products annually in each category.

The company is also increasing its investments in research and development to speed up new product introductions. Expansion efforts are underway in areas such as cardiology, critical care, and renal diagnostics, focusing on manufacturing to broaden its market presence. Baid noted plans to grow Polymed's presence in interventional cardiology and eventually expand into cardiac surgery products, structural heart devices, and electrophysiology.

By the end of this year, Polymed aims to capture 12-13% of the renal market in India, with further plans to expand this business globally. While 70% of the company's revenue in 2023-24 came from exports, it intends to push further into the European market, which currently accounts for about 30% of its export revenue. The next key markets targeted for expansion are the US and Latin America, with a continued focus on highly regulated geographies.

(Business Standard)

Related Stories

Process Equipment
Poly Medicure to use Rs 10 billion fundraise for capex and acquisitions

Poly Medicure to use Rs 10 billion fundraise for capex and acquisitions

Expansion efforts are underway in areas such as cardiology, critical care, and renal diagnostics, focusing on manufacturing to broaden its market presence.

Read more
Policy Regulation
Over 1,300 units operational under PLI scheme; to generate jobs

Over 1,300 units operational under PLI scheme; to generate jobs

Preliminary calculations suggest that the production of Rs 10 trillion under the PLI scheme should translate to incentives worth Rs 500 billion.

Read more
Process Equipment
Imports of medical device surged in India in fy23-34 to Rs 688.85 billion

Imports of medical device surged in India in fy23-34 to Rs 688.85 billion

This marks a 13% increase, with disposables accounting for nearly 17.6% of the growth.

Read more

Related Products

Programmable Controllers - Pcd-33a Series

CHEMICAL PROCESS, FOOD/PHARMA EQUIPMENT & ANALYTICAL INSTRUMENTS

Pro-Med Instruments (P) Ltd offers a wide range of programmable controllers - PCD-33A Series.


Read more

Request a Quote

Gasket Graphite Powder

CHEMICAL PROCESS, FOOD/PHARMA EQUIPMENT & ANALYTICAL INSTRUMENTS

Arihant Packing & Gasket Company offers a wide range of gasket graphite powder. 


Read more

Request a Quote

Asahi Kasei expands 3D printing filament sales in North America

CHEMICAL PROCESS, FOOD/PHARMA EQUIPMENT & ANALYTICAL INSTRUMENTS

Asahi Kasei, a leading resin and compounding technology provider, has initiated the sales of 3D printing (3DP) filaments in North America through Asahi Kasei Plastics North America (APNA). The soft la Read more

Request a Quote

Hi There!

Now get regular updates from IPF Magazine on WhatsApp!

Click on link below, message us with a simple hi, and SAVE our number

You will have subscribed to our Industrial News on Whatsapp! Enjoy

+91 84228 74016

Reach out to us

Call us at +91 8108603000 or

Schedule a Call Back